A citation-based method for searching scientific literature

Joan R Bloom, Susan L Stewart, Susan Chang, Myoungsoon You. Prev Med 2006
Times Cited: 21







List of co-cited articles
187 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Results of a randomized study of telephone versus in-person breast cancer risk counseling.
Almut W Helmes, Julie O Culver, Deborah J Bowen. Patient Educ Couns 2006
54
42

Effects of individualized breast cancer risk counseling: a randomized trial.
C Lerman, E Lustbader, B Rimer, M Daly, S Miller, C Sands, A Balshem. J Natl Cancer Inst 1995
349
23


Patients' resistance to risk information in genetic counseling for BRCA1/2.
Andrea D Gurmankin, Susan Domchek, Jill Stopfer, Christina Fels, Katrina Armstrong. Arch Intern Med 2005
63
23

Effects of a mammography decision-making intervention at 12 and 24 months.
Barbara K Rimer, Susan Halabi, Celette Sugg Skinner, Isaac M Lipkus, Tara S Strigo, Ellen B Kaplan, Gregory P Samsa. Am J Prev Med 2002
104
23

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
23

Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population.
Cecelia A Bellcross, Amy A Lemke, Laura S Pape, Angela L Tess, Lorraine T Meisner. Genet Med 2009
70
23


A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style.
C Lerman, M D Schwartz, S M Miller, M Daly, C Sands, B K Rimer. Health Psychol 1996
141
19

Effects of a mail and telephone intervention on breast health behaviors.
Deborah J Bowen, Diane Powers. Health Educ Behav 2010
20
20

Effects of risk counseling on interest in breast cancer genetic testing for lower risk women.
Deborah J Bowen, Wylie Burke, Yutaka Yasui, Anne McTiernan, Dale McLeran. Genet Med 2002
30
19

Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.
Patricia Ashton-Prolla, Juliana Giacomazzi, Aishameriane V Schmidt, Fernanda L Roth, Edenir I Palmero, Luciane Kalakun, Ernestina S Aguiar, Susana M Moreira, Erica Batassini, Vanessa Belo-Reyes,[...]. BMC Cancer 2009
41
19

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics.
A C Antoniou, R Hardy, L Walker, D G Evans, A Shenton, R Eeles, S Shanley, G Pichert, L Izatt, S Rose,[...]. J Med Genet 2008
129
19

Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.
Kimberly M Kelly, Leigha Senter, Howard Leventhal, Gozde Ozakinci, Kyle Porter. Patient Educ Couns 2008
13
30


Risk perception among women receiving genetic counseling: a population-based follow-up study.
Ellen M Mikkelsen, Lone Sunde, Christoffer Johansen, Søren P Johnsen. Cancer Detect Prev 2007
14
28

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
872
19

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes.
A C Antoniou, P D P Pharoah, G McMullan, N E Day, M R Stratton, J Peto, B J Ponder, D F Easton. Br J Cancer 2002
314
19


Development of a risk assessment tool for women with a family history of breast cancer.
Dejana Braithwaite, Stephen Sutton, James Mackay, Judith Stein, Jon Emery. Cancer Detect Prev 2005
26
19

The evolution of worry after breast cancer risk assessment: 6-year follow-up of the TRACE study cohort.
K Brain, E Parsons, P Bennett, R Cannings-John, K Hood. Psychooncology 2011
10
40

Longer-term influence of breast cancer genetic counseling on cognitions and distress: smaller benefits for affected versus unaffected women.
Arwen H Pieterse, Margreet G E M Ausems, Peter Spreeuwenberg, Sandra van Dulmen. Patient Educ Couns 2011
28
19

A systematic review of the impact of genetic counseling on risk perception accuracy.
Chris M R Smerecnik, Ilse Mesters, Eline Verweij, Nanne K de Vries, Hein de Vries. J Genet Couns 2009
85
19


Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
299
19

Validity of models for predicting BRCA1 and BRCA2 mutations.
Giovanni Parmigiani, Sining Chen, Edwin S Iversen, Tara M Friebel, Dianne M Finkelstein, Hoda Anton-Culver, Argyrios Ziogas, Barbara L Weber, Andrea Eisen, Kathleen E Malone,[...]. Ann Intern Med 2007
77
19

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Bernard Fisher, Joseph P Costantino, D Lawrence Wickerham, Reena S Cecchini, Walter M Cronin, Andre Robidoux, Therese B Bevers, Maureen T Kavanah, James N Atkins, Richard G Margolese,[...]. J Natl Cancer Inst 2005
842
19

Assessing BRCA carrier probabilities in extended families.
Carlos H Barcenas, G M Monawar Hosain, Banu Arun, Jihong Zong, Xiaojun Zhou, Jianfang Chen, Jill M Cortada, Gordon B Mills, Gail E Tomlinson, Alexander R Miller,[...]. J Clin Oncol 2006
71
19

A randomised comparison of UK genetic risk counselling services for familial cancer: psychosocial outcomes.
P Hopwood, D Wonderling, M Watson, A Cull, F Douglas, T Cole, D Eccles, J Gray, V Murday, M Steel,[...]. Br J Cancer 2004
20
20

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
19

The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.
A Finch, K A Metcalfe, J K Chiang, L Elit, J McLaughlin, C Springate, R Demsky, J Murphy, B Rosen, S A Narod. Gynecol Oncol 2011
129
19

Factors associated with intrusive cancer-related worries in women undergoing cancer genetic risk assessment.
Paul Bennett, Clare Wilkinson, Jim Turner, Rhiannon Tudor Edwards, Barbara France, Gethin Griffith, Jonathon Gray. Fam Cancer 2009
15
26

A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO.
D G R Evans, D M Eccles, N Rahman, K Young, M Bulman, E Amir, A Shenton, A Howell, F Lalloo. J Med Genet 2004
184
19

A randomised controlled trial of breast cancer genetics services in South East Scotland: psychological impact.
A Fry, A Cull, S Appleton, R Rush, S Holloway, D Gorman, R Cetnarskyj, R Thomas, J Campbell, E Anderson,[...]. Br J Cancer 2003
38
19

Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study.
Yvonne Brandberg, Kerstin Sandelin, Staffan Erikson, Göran Jurell, Annelie Liljegren, Annika Lindblom, Ann Lindén, Anna von Wachenfeldt, Marie Wickman, Brita Arver. J Clin Oncol 2008
146
19

Selecting a BRCA risk assessment model for use in a familial cancer clinic.
Seema M Panchal, Marguerite Ennis, Sandra Canon, Louise J Bordeleau. BMC Med Genet 2008
34
19


Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
L C Hartmann, D J Schaid, J E Woods, T P Crotty, J L Myers, P G Arnold, P M Petty, T A Sellers, J L Johnson, S K McDonnell,[...]. N Engl J Med 1999
927
19

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
276
14

Pre-counseling education materials for BRCA testing: does tailoring make a difference?
Celette Sugg Skinner, Joellen M Schildkraut, Donald Berry, Brian Calingaert, P Kelly Marcom, Jeremy Sugarman, Eric P Winer, J Dirk Iglehart, P Andrew Futreal, Barbara K Rimer. Genet Test 2002
51
14

Effects of colon cancer risk counseling for first-degree relatives.
Karen Glanz, Alana D Steffen, Lauren A Taglialatela. Cancer Epidemiol Biomarkers Prev 2007
40
14

Comparisons of tailored mammography interventions at two months postintervention.
Victoria L Champion, Celette Sugg Skinner, Usha Menon, Roopa Seshadri, Deborah C Anzalone, Susan M Rawl. Ann Behav Med 2002
48
14


Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent.
K K Oros, P Ghadirian, C M Maugard, C Perret, Y Paredes, A-M Mes-Masson, W D Foulkes, D Provencher, P N Tonin. Clin Genet 2006
23
14

Effect of raloxifene on the incidence of invasive breast cancer in postmenopausal women with osteoporosis categorized by breast cancer risk.
Marc E Lippman, Steven R Cummings, Damon P Disch, John L Mershon, Sherie A Dowsett, Jane A Cauley, Silvana Martino. Clin Cancer Res 2006
39
14

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
B B Roa, A A Boyd, K Volcik, C S Richards. Nat Genet 1996
553
14


Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.
J Peto, N Collins, R Barfoot, S Seal, W Warren, N Rahman, D F Easton, C Evans, J Deacon, M R Stratton. J Natl Cancer Inst 1999
641
14

Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.
Trevor J Powles, Sue Ashley, Alwynne Tidy, Ian E Smith, Mitch Dowsett. J Natl Cancer Inst 2007
268
14

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.
Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin, Reena S Cecchini, James N Atkins, Therese B Bevers, Louis Fehrenbacher, Eduardo R Pajon, James L Wade,[...]. Cancer Prev Res (Phila) 2010
392
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.